Rodent models of fatty liver diseases
Abstract
Fatty liver diseases including alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver diseases worldwide. ALD and NAFLD encompass a broad spectrum of liver disorders ranging from simple steatosis to steatohepatitis, fibrosis, cirrhosis and superimposed hepatocellular carcinoma. Despite considerable advances in our understanding of the pathogenesis of fatty liver diseases over the past 40 years, effective diagnostic, prognostic, and therapeutic tools are still lacking. The use of animal models is crucial to investigate the cellular and molecular mechanisms underlying the development and progression of fatty liver diseases and develop novel therapeutic strategies. Although no animal model to date can faithfully replicate all the clinical and histological features of ALD or NAFLD, existing models can mimic specific aspects of human diseases. This review provides an overview of the most commonly used and recently developed rodent models of ALD and NAFLD and discusses their major strengths and shortcomings.
Related
- Identification of co-expressed gene sets for major molecular initiating events in rodent liver carcinogenesis using wild type and knock out rats
- Omics-based Decoding of Metabolic Dysfunction-associated Fatty Liver Disease: From Pathogenesis to Clinical Translation
- Metabolic dysfunction-associated fatty liver disease and long-term kidney function decline: a 16-year population-based cohort study
- Association between the fasting blood glucose to high-density lipoprotein cholesterol ratio and non-alcoholic fatty liver disease in Chinese adults: a secondary analysis
- Role of the Hepatorenal Index in the Detection of HbA1c-Defined Dysglycemia in Patients With Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
BibTeX
@article{bertola2026rodent,
title = {{Rodent models of fatty liver diseases}},
author = {Adeline Bertola},
journal = {Liver Research},
year = {2026},
month = oct,
doi = {10.1016/j.livres.2018.03.001},
url = {https://hal.science/hal-05795810v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Rodent models of fatty liver diseases
AU - Adeline Bertola
PY - 2026
DA - 2026/10/12
JO - Liver Research
DO - 10.1016/j.livres.2018.03.001
UR - https://hal.science/hal-05795810v1
AB - Fatty liver diseases including alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are leading causes of chronic liver diseases worldwide. ALD and NAFLD encompass a broad spectrum of liver disorders ranging from simple steatosis to steatohepatitis, fibrosis, cirrhosis and superimposed hepatocellular carcinoma. Despite considerable advances in our understanding of the pathogenesis of fatty liver diseases over the past 40 years, effective diagnostic, prognostic, and therapeutic tools are still lacking. The use of animal models is crucial to investigate the cellular and molecular mechanisms underlying the development and progression of fatty liver diseases and develop novel therapeutic strategies. Although no animal model to date can faithfully replicate all the clinical and histological features of ALD or NAFLD, existing models can mimic specific aspects of human diseases. This review provides an overview of the most commonly used and recently developed rodent models of ALD and NAFLD and discusses their major strengths and shortcomings.
SN - 2542-5684
ER -